Today

Agents

Chat

Arena

Discover

More

App

Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million - AUPH News | Rallies

Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million

AUPH•2026-08-06

Second-quarter results

Aug. 6 (Reuters) - Aurinia Pharmaceuticals Q2 product revenue was USD 79.412 million.

Q2 pretax profit: USD 48.786 million
Q2 net income: USD 37.414 million
Q2 operating income: USD 46.341 million
Q2 operating expenses: USD 36.879 million

Related News

Copel targets 2.9x net debt-to-Ebitda leverage under updated capital structure plan

ELP•2026-08-06

AquaBounty expands Pioneer Ohio strategic review to target power and energy infrastructure development opportunities

AQB•2026-08-06

Insulet Corporation <PODD.O>: Benchmark cuts target price to $185 from $250

PODD•2026-08-06

Vystar issues 8,371 Series B preferred shares in unregistered sale tied to r3alm venture

VYST•2026-08-06

Dave Inc. <DAVE.O>: B. Riley Raises Target Price to $449 From $370

DAVE•2026-08-06